top of page

Capital and Investments

CO-AX support you in each stage of your financial journey.

We support you and make sure to put you in the best position to get investor ready, from doing a great pitch to guidance on cap table, DD and financial plan. We introduce you to an excessive network of investors and strategic partners. We guide you to the best demo days and other events where you meet investors and secure funding.

Capital and Investments
CAPITAL AND INVESTMENTS

In the healthtech startup journey, securing capital at various stages is a strategic process aimed at fueling growth, validating the business model, and ultimately scaling the innovation to make a market impact.

At each stage, startups typically raise funds in exchange for equity, gradually ceding portions of ownership as they bring on investors who provide the necessary resources to progress. This journey begins with early funding rounds like the seed stage, often supported by angel investors or seed funds, with a focus on developing the core product, conducting preliminary market research, and validating the business model. In this phase, capital is vital for initial R&D, securing early talent, and perhaps even navigating the initial stages of regulatory compliance in the health sector.

As the startup proves its concept and gathers early traction, it moves into Series A funding. At this point, venture capital (VC) firms step in with larger investments to drive further growth. Series A capital is generally earmarked for expanding operational capacity, hiring additional team members, and scaling up marketing efforts to reach a broader audience. For healthtech companies, this phase may also involve refining the product based on user feedback, securing key partnerships within the healthcare industry, and preparing for rigorous compliance standards. The focus in Series A is to accelerate growth, solidify market positioning, and begin establishing the infrastructure necessary for larger-scale operations.

With successful milestones and proven growth potential, healthtech startups progress into later funding rounds—Series B, C, and beyond—each involving increasingly substantial amounts of capital to support more ambitious growth goals. In Series B, capital is often used to deepen market penetration, optimize business processes, and potentially expand to new geographic regions. Healthtech companies in this stage may also look to enhance their technological capabilities or diversify product offerings to gain a competitive edge. Series C and later rounds are typically pursued by startups that have achieved a solid market position and are ready for large-scale expansion. These rounds support significant growth initiatives, such as acquiring other companies, entering international markets, or even preparing for an initial public offering (IPO).

The pitch is a crucial element in a startup's journey to secure capital. It's the startup’s chance to make a compelling, concise case for why investors should believe in its vision and invest in its potential. A strong pitch not only conveys the problem the startup addresses and the solution it provides, but it also demonstrates a clear business model, market opportunity, and the founder’s understanding of both challenges and growth opportunities in the healthtech space. It should also describe traction and milestones aswell as team composition, regulatory strategy and a clear financial plan.

Siddhartha Khandelwal
Siddhartha Khandelwal

Investor relations Manager

Email

+46 76 020 53 91

Together, these elements strengthen a pitch, helping startups make a memorable impression and increase their likelihood of securing capital.

bottom of page